Pricing updated 2019-06-15. Prices are subject to change without notice.
AP-III-a4 is a small molecule enolase inhibitor (IC50 = 0.576 µM) that inhibited cancer cell metastasis in an in vivo zebrafish cancer cell xenograft model.1 It also reduced hyperglycemia and hyperlipidemia in C57BL/Ksj-db/db mice, a transgenic model of type 2 diabetes.2 Another study found that AP-III-a4 did not directly block enolase activity in vitro and suggested the mechanism is indirect.3
Warning - this product is not for human or veterinary use.
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Cho, H., Um, J., Lee, J.-
Satani, N., Lin, Y.-